Related Experiment Video
Updated: Jun 19, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Translating genome-wide association studies at multiple scales: Drug target prioritization, cellular architectures,
Benedetta Felici1, Siyuan Chen1, Meng Yuan1
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
None:
With a vast corpus of findings from nearly two decades of genome-wide association studies (GWASs), many studies now focus on translating these genetic associations into biological insights at multiple scales, from proteins and cells to entire organs. This approach will help build the foundation for the next generation of treatments. In this review, we highlight key recent studies that have informed target prioritization and drug repurposing, linked genetic variants to gene regulation in cellular contexts, and uncovered the genetic architecture of organ structure and function. Nearly 25 years after the initial draft of the human genome, it is clear that genomics is driving tangible advances in therapies and opening new ways to understand multi-scale biology.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview
